Actively Recruiting

Phase Not Applicable
Age: 50Years +
All Genders
NCT06446817

Bicentric Clinical Investigation to Assess Safety and Performance of LuxHighAdd IOL

Led by Cutting Edge SAS · Updated on 2025-02-12

57

Participants Needed

2

Research Sites

79 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The study purpose is to demonstrate safety and performance of bilateral implantation of LuxHighAdd intraocular lens compared with the LuxGood Monofocal lens.

CONDITIONS

Official Title

Bicentric Clinical Investigation to Assess Safety and Performance of LuxHighAdd IOL

Who Can Participate

Age: 50Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Subject aged 50 or over on the day of inclusion, presenting a bilateral cataract, qualified for bilateral implantation
  • No ocular comorbidity possibly affecting the study results
  • Fit within the available IOL diopter range
  • Have had no previous refractive surgery
  • Regular corneal astigmatism ≤1.0 dioptres
  • Clear intraocular media other than cataract
  • Availability, willingness and sufficient cognitive awareness to comply with examination procedures
  • Ability to attend all study follow-ups
  • Signed informed consent.
Not Eligible

You will not qualify if you...

  • Ocular surface disease potentially affecting study results
  • Pre-existing ocular pathology or history of pathology potentially affecting the study results
  • Acute or chronic disease or illness that would increase risk or confound study results
  • Subjects who may be reasonably expected to require a secondary surgical intervention at any time during the investigation (other than YAG capsulotomy)
  • Axial lengths and keratometry such as the IOL spherical power is not in the range of 16 to 26 D
  • Instability of keratometry or biometry measurements
  • Traumatic cataract
  • Amblyopia
  • History of ocular trauma or any prior ocular surgery including refractive procedures
  • Capsular or zonular abnormalities that may affect postoperative centration or tilt of the lens
  • Pupil abnormalities
  • Systemic or ocular medication that could modify pupil dynamics
  • Expected complicated surgery or complicated surgery
  • Concurrent participation in another drug or device investigation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Hôpital Fondation Adolphe de Rothschild

Paris, France, 75019

Actively Recruiting

2

WestOphta

Rennes, France, 35000

Actively Recruiting

Loading map...

Research Team

L

Line Bettinelli, OD

CONTACT

C

Christophe Cesses

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here